Barry Callebaut AG (BRRLY) Fair Value & Analysis
Consumer Defensive · US · Market cap $7.6B
Analysis
Barry Callebaut AG (BRRLY) currently trades at $14.14, while our model-based Fair Value estimate is $9.82 — implying the stock looks roughly 30.5% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Barry Callebaut AG, together with its subsidiaries, engages in the manufacture and sale of chocolate and cocoa products in Western Europe, North America, Central and Eastern Europe, Latin America, and internationally. It operates in two segments, Global Chocolate and Global Cocoa. It offers chocolates, chips and chunks, cocoa, cacao fruit, fillings, coatings, nuts, decorations and inclusions, and food colorants, as well as beverage products for vending machines. The company is also involved in the sourcing of ingredients for chocolate production and cocoa-processing business. In addition, it provides centralized treasury and management services, captive reinsurance, research and development services, and conference and training services through CHOCOLATE ACADEMY centers. The company markets its products under the American Almond, Barry Callebaut, Cacao Barry, Cacaofruit, Callebaut, Caprimo, Carma, Dings Décor, Gertrude Hawk Ingredients, Mona Lisa, Van Houten, and Van Leer Chocolates…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.